[
  {
    "ref_criterion": "Acknowledges irreducible uncertainty due to limited evidence on the use of topical cannabis-based preparations for pain management.",
    "ref_axis": "accuracy",
    "ref_point": 10,
    "gen_criterion": "Provides a clear and concise summary of the existing evidence on the use of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.6644,
    "point_diff": 2,
    "score": 0.664,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Uses available systematic reviews as a reference framework to build the answer.",
    "ref_axis": "accuracy",
    "ref_point": 10,
    "gen_criterion": "Uses natural language and correct interpretation, taking into account the user's request and context",
    "gen_axis": "communication_quality",
    "gen_point": 7,
    "similarity": 0.3137,
    "point_diff": 3,
    "score": 0.314,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Explains that there are still no robust, long-term clinical trials that conclusively demonstrate the efficacy and safety of cannabis-based topical preparations for neuropathic pain.",
    "ref_axis": "accuracy",
    "ref_point": 9,
    "gen_criterion": "States that there is no evidence of the effectiveness of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "accuracy",
    "gen_point": -8,
    "similarity": 0.7308,
    "point_diff": 17,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Provides incorrect information about valid references. Xu DH et al. (2019) published a study on a topical formulation of CBD in patients with neuropathic pain, not a review. Eskander et al. (2020) reported two patients using a CBD cream for neuropathic and radicular pain, not a study with 29 patients.",
    "ref_axis": "accuracy",
    "ref_point": -8,
    "gen_criterion": "Provides a clear and concise summary of the existing evidence on the use of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.6302,
    "point_diff": 16,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Mentions that the most commonly reported adverse effects are generally local, such as skin irritation, contact dermatitis, and pruritus, and warns that diabetic patients with sensitive skin or peripheral nerve damage may be more susceptible to adverse reactions.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Provides a clear and concise summary of the existing evidence on the use of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.4426,
    "point_diff": 1,
    "score": 0.443,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Mentions that with topical application, systemic absorption appears to be low but not zero, posing a risk of systemic side effects (e.g., sedation or dizziness), and it is still unknown if there is any risk of interaction with other medications.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Provides a list of potential side effects of cannabis-based creams, including dizziness, nausea, and anxiety",
    "gen_axis": "accuracy",
    "gen_point": 6,
    "similarity": 0.3986,
    "point_diff": 2,
    "score": 0.399,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Suggests that if the therapy is chosen, only products whose quality, safety, and composition can be confirmed should be used.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "States that the patient should consult a healthcare professional before using cannabis-based creams",
    "gen_axis": "instruction_following",
    "gen_point": 6,
    "similarity": 0.4501,
    "point_diff": 1,
    "score": 0.45,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Mentions that data on long-term, chronic effects of topical cannabinoid use are still lacking.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Mentions potential risks associated with long-term use of cannabis-based creams, such as addiction, cardiovascular issues, and cognitive impairment",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.6891,
    "point_diff": 2,
    "score": 0.689,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Advises informing the patient about the limitations of the evidence and the possibility of local side effects, and discussing realistic expectations regarding pain relief before starting the treatment.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Asks the user to provide more information about their patient's condition to better understand their needs",
    "gen_axis": "context_awareness",
    "gen_point": 5,
    "similarity": 0.4988,
    "point_diff": 3,
    "score": 0.499,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Misses to explain that cannabidiol, compared to THC, has shown stronger anti-inflammatory and analgesic properties when applied topically and has shown better results in neuropathic or musculoarticular pain, probably through actions on endocannabinoid system receptors and other receptors related to pain modulation. However, the quality of evidence is not strong enough due to multiple methodological limitations.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Provides a clear and concise summary of the existing evidence on the use of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.591,
    "point_diff": 15,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Recommends that the treatment could be considered as an alternative therapy for neuropathic pain with close monitoring of efficacy and adverse effects, to be left to the discretion of the treating physician and in a joint decision-making setting with the patient.",
    "ref_axis": "completeness",
    "ref_point": 6,
    "gen_criterion": "Provides a clear and concise summary of the existing evidence on the use of cannabis-based creams for diabetic neuropathic pain",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.4166,
    "point_diff": 2,
    "score": 0.417,
    "similar_match": false,
    "axis_match": true
  }
]